The Most Soothing Powerful Color Coded Solution For Prevention Ofaquired Healthcare Infections (AHI)

Share Article

CIO Max Gascoine PhD has announced the availability for evaluation of their innovative biotechnology environmental topical skin biocides for acquired healthcare infection control.

This biotechnology brings a new high level of desirability resulting in enhanced hand hygiene compliance and novel cost effective monitoring of healthcare personnel.

A Dr. Shumway Stanford trained Heart Transplant Surgeon since 1983, Dr. John Macoviak MD stated, "The added advantage of this product is that it can be used for a personnel scrub or a patient prep throughout all healthcare facilities, it is universal in application unlike competing products in this space. More importantly it is safer and more cost effective than competing products.”

About Annuary Healthcare, Inc

John A. Macoviak has worked with the AHI team for sixteen months developing, testing and refining this first in a line of novel biotechnologies to address an unresolved major problem in healthcare today. Current products are not being successful in preventing the under-reported incidence of over 1.7M acquired healthcare infections that currently cause more than 100,000 deaths each year in the US.

For more information on the product, visit http://www.annuaryhealthcare.com or contact:
Media contact:
Max Gascoine, CIO
mgascoine(at)annuaryhealthcare(dot)com
760-877-9011

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Max Gascoine
mgascoine@annuaryhealthcare.com
7608779011
Email >
Visit website